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LETTER TO THE EDITOR
Streptococcus bovis infectious 
endocarditis and occult gastrointestinal 
neoplasia: experience with 25 consecutive 
patients treated surgically
Anthony Alozie1*, Kerstin Köller2, Lumi Pose1, Maximilian Raftis1, Gustav Steinhoff1, Bernd Westphal1, 
Georg Lamprecht3 and Andreas Podbielski2
Abstract 
To assess the prevalence of gastrointestinal neoplasia in patients with Streptococcus bovis infectious endocarditis we 
performed a retrospective cohort analysis of all episodes of S. bovis infectious endocarditis treated at our institution 
between January 2000 through December 2014. Twenty-five patients were identified for this purpose. 12/25 patients 
received colonoscopy and 1/25 of the patients was assessed with CT colonography. Of the 13 who underwent 
colonic assessment, 11 were diagnosed with colonic neoplasms at different stages of development. In the absence of 
any strong contraindication, gastroenteroscopic evaluation in all patients diagnosed with S. bovis infectious endocar-
ditis should be pursued.
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Background
Streptococcus bovis (S. bovis), is a commensal inhabitant 
of the human digestive tract. It may be isolated in up to 
35 % of fecal samples from human rectal swab [1]. Since 
the first remarkable case of the association between an 
enterococcal infection and colorectal carcinoma pre-
sented by McCoy et al. in 1951 and the case control study 
by Klein et  al. over two decades later, the association 
between S. bovis bacteremia and colorectal neoplasia has 
been thoroughly well established in the literature [2–4]. 
The involvement of S. bovis in infectious endocarditis (IE) 
was put at approximately 6  % [5, 6], which means that 
IE is another important variable associated with the two 
phenomena. A systematic review of 31 studies published 
by Boleij et al. in 2011 found that 65 % of patients infected 
by S. bovis, in addition to high levels of IE, were also diag-
nosed with concomitant colorectal neoplasias [7]. The 
picture became more complex, because genomic analysis 
revealed that “S. bovis” isolates in fact belonged to at least 
seven different species or subspecies, i.e. S. gallolyticus 
ssp. gallolyticus, S. gallolyticus ssp. pasteurianus, S. gallo-
lyticus ssp. macedonius, S. infantarius ssp. infantarius, S. 
infantarius ssp. coli [S. lutetiensis], S. alactolyticus, and 
S. equines. S. gallolyticus ssp. is more often encountered 
in human specimens than the two other species/subspe-
cies. Especially S. gallolyticus ssp. gallolyticus bactere-
mias were demonstrated to be associated with colorectal 
cancer [8, 9]. For reasons of simplicity these strains are 
furtheron addressed as S. bovis-group isolates.
Reported colorectal neoplasia encompassed adenomas 
with neoplastic potential, which included tubular, tub-
ulo-villous and villous adenomas. Given this relationship 
between S. bovis-group bacteremia and colorectal neopla-
sia, patients with IE treated conservatively or surgically 
should be promptly evaluated for presence of gastrointes-
tinal neoplasia, since colorectal neoplasia seem to be the 
preferred colonization site for S. bovis-group strains [7].
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Methods
Etiologic diagnosis of S. bovis-group IE in 25 patients 
treated surgically between January 2000 and Decem-
ber 2014 in our heart center was obtained by blood cul-
ture and direct valve culture results. Routine 16 sRNA 
PCR of all intra operatively excised heart valves from 
IE patients was introduced from year 2007. Blood cul-
ture isolates from external hospitals and those obtained 
prior to 2007 were not further characterized by molecu-
lar genetic methods (8 isolates). However, full-length 16 
sRNA PCR gene sequences of blood and heart valve cul-
tures obtained during the later years clearly assigned the 
strains to S. gallolyticus subsp gallolyticus (16) and Strep-
tococcus lutetiensis (1). Clinical information was obtained 
from the patient clinical record. This included presenting 
symptoms, examination findings, and investigation results 
from echocardiography, abdominal sonography, com-
puted tomography for general screening purposes and 
gastroscopy/colonoscopy. Clinical records were reviewed 
for data regarding demographics, medical co-morbidi-
ties, clinical presentation, investigations, surgical inter-
ventions, clinical outcome and follow up management. 
A questionnaire was submitted to each patient’s general 
practitioner to assess current health status. A telephone 
interview was made if the questionnaire was not returned.
Diagnosis of IE was established by a team of cardiolo-
gists, heart surgeons, microbiologists and pathologists 
applying the modified Duke criteria [10].
Microbiology
Processing of blood cultures followed the established 
standards of the German Society for Hygiene and Micro-
biology (DGHM). The microbiology laboratory of Ros-
tock University Medicine is accredited according to DIN 
EN ISO 15183 for these tests as well as for the PCR exam-
inations. DNA extraction was performed with the Qiagen 
DNA Mini Kit (QIAGEN, Hilden, Germany) according 
to the manufacturer’s protocol. Nucleic acid concen-
tration was measured using a biophotometer (Eppen-
dorf, Hamburg, Germany). For 16S rDNA PCR primers, 
16S8_27 and 16S_907 and polymerase moltaq (molzym) 
were utilized [11, 12]. The following reaction conditions 
were chosen: (1) 15 min at 94 °C; (2) 30× [1 min at 94 °C, 
1 min at 50  °C, 1 min at 72  °C]; (3) 5 min at 72  °C [11, 
12]. PCR products were determined by gel electrophore-
sis, purified with the NAT CLEAN-UP/NUCLEOSPIN® 
EXTRACT II (Machery-Nagel, Düren, Germany) and 
subsequently sent to Microsynth Sequencing Device 
(Göttingen, Germany) for the actual sequencing reaction. 
Sequence analysis was performed using NCBI nucleo-
tide blast search (http://www.ncbi.nlm.nih.gov), resulting 
in identification of various species of the S. bovis-group 
(Table 1).
Results
Twenty-five S. bovis-group IE episodes with avail-
able patient clinical data were identified. These were 
in 23 males and 2 females. Mean age was 63.9 (range 
40–84 years).
A definite IE according to the duke criteria was estab-
lished preoperatively in all patients and confirmed by 
post surgical histological and microbiological process-
ing of every single excised heart valve. Sixteen of the IE 
episodes were caused by S. gallolyticus subsp. gallolyticus 
and the remaining nine cases by 1 S. lutetiensis and 8 iso-
lates of the S. bovis-group with no further differentiation.
Of the 25 patients examined, 13 received gastroent-
eroscopic assessment for gastrointestinal neoplasia post 
surgery by means of gastroscopy, colonoscopy and ct 
colonography. Of these 13 patients, 11 had gastroentro-
logic neoplasia (84.6 %). Detailed evaluation of gastroen-
teroscopic findings in 11 of the 13 patients assessed are 
depicted in Table 1. One patient with ethyl toxic liver cir-
rhosis and esophagus varices grade III° at time of surgery 
who refused colonoscopy was diagnosed with colo-sig-
moid carcinoma 6 years later.
Discussion
The clinical relationship between S. bovis-group bacte-
remia and underlying gastrointestinal malignancies or 
premalignant adenomatous polyps has been well known 
for many years [2, 3]. Although this association has 
huge clinical implications for both patients and physi-
cians being entrusted with further management of these 
patients both during major illnesses and thereafter, we 
found unsatisfactory awareness of this among family doc-
tors. This is reflected in the unacceptably low number 
of patients we observed in this study obtaining gastro-
enteroscopic evaluation after hospital discharge. Those 
patients who did obtain gastroenteroscopic evaluation, 
only received this during their hospital stay. Of those who 
were discharged without gastroenteroscopic evaluation, 
lack of compliance was often noted, but the remaining 
patients were probably not followed up as required. One 
patient in our series was diagnosed with colonic adeno-
carcinoma 6  years later, after he had refused gastroin-
testinal evaluation post surgery. We speculate that this 
occurrence could probably have been prevented if a colo-
noscopy had been obtained in the first place.
The rate of patients undergoing colonic evaluation in 
our study (52  %) did not significantly differ from those 
reported in previous literature [13, 14] (70 and 50  %) 
although it was far lower than those reported by Ballet 
et  al. (81 %) and Tripod et  al. (96 %) [15, 16]. However, 
the prevalence of colonic malignancies or premalignan-
cies we found in those patients subjected to gastroentero-
scopic evaluation 13/25 is in between those reported in 
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Table 1 Patients baseline characteristics, gastrointestinal findings and underlying conditions
CLL chronic lymphocytic leucemia, BPH benign prostate hyperplasia, PEG-interferone pegylated interferone
Pat.  
nr
Age/sex Year Bio-type IE Bowel evaluation Findings Underlying conditions
1 64/m 2003 S. bovis Definite Gastroscopy, colonoscopy Two 1–1.5 cm tubular sessile 
adenoma, intermediate 
dysplasia
CLL, microcytic anemia, BPH, 
carcinoma of prostate 
3 years later
2 49/m 2004 S. bovis Definite Declined Colosigmoid adenocarci-
noma 5 years later
Alcohol toxic liver cirrhosis, 
esophagus varices III°
3 69/m 2004 S. bovis Definite Gastroscopy, colonoscopy Gastritis Gastritis, colostoma (post 
sigma ishemia)
4 49/m 2005 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy Two 1 cm tubular colon 
adenoma low grade 
dysplasia
None
5 64/m 2007 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy Five 1–2 cm polyps, with 
high grade suspicion for 
coecum carcinoma
None
6 72/m 2007 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – None
7 53/m 2008 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – None
8 70/m 2008 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – Hepatitis C, PEG interferone, 
dialysis
9 73/m 2009 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy 2 × 2 cm tubular Polyps, 
high grade suspicion for 
carcinoma 2014
Liver cirrhosis, psoriasis
10 54/m 2009 S. gallolyticus subsp. 
gallolyticus
Definite Gastroscopy, colonoscopy Pangastritis, 2× broad 
based colonic adenoma
Pangastritis
11 70/m 2009 S. gallolyticus subsp. 
gallolyticus
Definite Lost to follow up – Spinal abscess surgery
12 57/m 2009 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy Diverticulosis of small/large 
intestine
13 74/m 2010 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy/gastroscopy Broad based stomach Polyp Spondylodiscitis
14 66/m 2010 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – None
15 77/m 2011 S. bovis Definite CT colonography Normal Steatosis hepatis, BPH
16 48/m 2012 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy 4 Colonic polyps, 7–15 mm; 
stomach polyp, mucus-
producing tumor left 
colonic flexure
Liver cirrhosis child B, 
esophagus varices II°
17 60/m 2012 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – None
18 63/f 2012 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – None
19 68/m 2013 S. gallolyticus subsp. 
gallolyticus
Definite Colonoscopy Colonic polyp None
20 57/m 2013 S. gallolyticus subsp. 
gallolyticus
Definite No colonoscopy – Hepatitis B, chronic alcohol 
abuse
21 84/m 2000 S. bovis Definite Colonoscopy Multiple colonic polyps up 
to 1 cm each
Cholecystolithiasis, spleno-
megaly
22 65/m 2000 S. bovis Definite No colonoscopy – Ethyl toxic liver insufficiency, 
esophagus varices III°
23 78/m 2014 S. lutetiensis Definite Colonoscopy Colonic and rectal polyps 
resected
None
24 40/m 2000 S. bovis Definite No colonoscopy – Hepatitis C and HIV
25 74/f 2007 S. bovis Definite No colonoscopy – Dialysis due to cystic kidney 
disease
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other studies, with a similar number of patients subjected 
to colonic evaluation (33 %, Coffey and 86 % Vaska) [13, 
14]. S. gallolyticus subsp. gallolyticus has a median colo-
rectal neoplasia prevalence among S. bovis bacteraemia 
patients of 60–67 % but only 25 % prevalence in the gen-
eral population that underwent colonoscopy, showing the 
clear association of S. gallolyticus subsp. gallolyticus with 
colorectal neoplasia [9]. Current medical recommenda-
tions therefore advice to perform colonoscopy for any 
patient diagnosed with S. gallolyticus subsp. gallolyticus 
bacteraemia due to the 2/3 association of S. gallolyticus 
subsp. gallolyticus with colorectal neoplasia and 21  % 
yielding de facto colorectal carcinomas [9].
Of all 13 patients in our study that obtained colonic 
evaluation, 11 had colonic malignancies or premalig-
nancies (84.6 %). Since our study is neither randomized 
nor prospective in nature, we cannot exclude the pos-
sibility that these results are obtained by chance. How-
ever, our results are in line with other studies with high 
prevalence of malignancies or premalignancies of the 
colon with the same setting [13]. We admit that there 
is a wide range between reported prevalence of gastro-
intestinal neoplasia during S. bovis bacteremia, rang-
ing from 6 % in the retrospective analysis presented by 
Pigrau et al. to 86 % as reported in a retrospective study 
by Vaska et al. [17]. This may be partly due to the retro-
spective nature of these studies, as a limited amount of 
patients underwent bowel evaluation after episodes of 
bacteremia.
Conclusion
Adenomatous polyps are tumors of benign neoplastic epi-
thelium with variable potential for malignancy. The ade-
noma-carcinoma sequence is well known and it is accepted 
that more than 95 % of colorectal cancers arise from ade-
nomas [18]. Though, to date there has been no satisfactory 
explanation regarding the pathophysiological mechanism 
behind this association. We admit that we were not able 
to provide precise differentiation between all species and 
subspecies, a factor necessary for correct risk assessment 
of every diagnosis. In consideration of this fact, we strongly 
advocate subtyping of every single case of S. bovis bacte-
raemia and gastroenteroscopic assessment in all patients 
diagnosed and treated for S. bovis-group IE during or soon 
after their index admission, as 84.4 % of our patients who 
obtained this assessment had colorectal neoplasia.
Authors’ contributions
AA drafted the manuscript and collected clinical data. KK and AP carried 
out microbiological analysis including PCR and sequencing analysis and 
drafted part of the manuscript. LP and MR collected clinical data. GS and 
BW participated in coordination and design of the study. GL carried out 
gastroenteroscopic assessment of the patients. All authors read and approved 
the final manuscript.
Author details
1 Department of Cardiac Surgery, University Heart Center Rostock, Schillingal-
lee 35, 18057 Rostock, Germany. 2 Institute of Medical Microbiology, Virology 
and Hygiene, University Hospital Rostock, Schillingallee 70, 18055 Rostock, 
Germany. 3 Zentrum für Innere Medizin, Klinik II -Abteilung für Gastroenterol-
ogy, Ernst-Heydemann-Str. 6, 18057 Rostock, Germany. 
Competing interests
The authors declare that they have no competing interests.
Received: 18 June 2015   Accepted: 23 September 2015
References
 1. Lopes PG, Cantarelli VV, Agnes G, Costabeber AM, d’Azevedo PA. Novel 
real-time PCR assays using TaqMan minor groove binder probes for iden-
tification of fecal carriage of Streptococcus bovis/Streptococcus equinus 
complex from rectal swab specimens. J Clin Microbiol. 2014;52:974–6.
 2. McCoy WC, Mason JM 3rd. Enterococcal endocarditis associated with 
carcinoma of the sigmoid; report of a case. J Med Assoc State Ala. 
1951;21:162–6.
 3. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. 
Association of Streptococcus bovis with carcinoma of the colon. N Engl J 
Med. 1977;297:800–2.
 4. Boleij A, Tjalsma H. The itinerary of Streptococcus gallolyticus infec-
tion in patients with colonic malignant disease. Lancet Infect Dis. 
2013;13:719–24.
 5. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363:139–49.
 6. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer 
AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Hol-
land DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang 
A, Woods CW, Cabell CH, International Collaboration on Endocarditis-
Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, 
etiology, and outcome of infective endocarditis in the 21st century: the 
International Collaboration on Endocarditis-Prospective Cohort Study. 
Arch Intern Med. 2009;169:463–73.
 7. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical impor-
tance of Streptococcus gallolyticus infection among colorectal 
cancer patients: systematic review and meta-analysis. Clin Infect Dis. 
2011;53:870–8.
 8. Jans C, Meile L, Lacroix C, Stevens MJ. Genomics, evolution, and 
molecular epidemiology of the Streptococcus bovis/Streptococcus equinus 
complex (SBSEC). Infect Genet Evol. 2015;33:419–36.
 9. Corredoira J, García-País MJ, Coira A, Rabuñal R, García-Garrote F, Pita J, 
Rodríguez-Macías A, Blanco M, Lopez-Roses L, López-Álvarez MJ, Alonso-
García MP. Differences between endocarditis caused by Streptococcus 
bovis and Enterococcus spp. and their association with colorectal cancer. 
Eur J Clin Microbiol Infect Dis. 2015;34:1657–65.
 10. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey 
GR. Proposed modifications to the Duke criteria for the diagnosis of infec-
tive endocarditis. Clin Infect Dis. 2000;30:633–8.
 11. Zheng D, Alm EW, Stahl DA, Raskin L. Characterization of universal small-
subunit rRNA hybridization probes for quantitative molecular microbial 
ecology studies. Appl Environ Microbiol. 1996;62:4504–13.
 12. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA ampli-
fication for phylogenetic study. J Bacteriol. 1991;173:697–703.
 13. Vaska VL, Faoagali JL. Streptococcus bovis bacteraemia: identification 
within organism complex and association with endocarditis and colonic 
malignancy. Pathology. 2009;41:183–6.
 14. Coffey S, Nadarasa K, Pan A, van der Linden A, Chu J, Schultz M. The 
increasing incidence of Streptococcus bovis endocarditis and bacteraemia: 
a case series from 1997 to 2010. Int J Cardiol. 2012;161:111–3.
Page 5 of 5Alozie et al. Gut Pathog  (2015) 7:27 
 15. Ballet M, Gevigney G, Garé JP, Delahaye F, Etienne J, Delahaye JP. Infective 
endocarditis due to Streptococcus bovis. A report of 53 cases. Eur Heart J. 
1995;16:1975–80.
 16. Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi 
D, Ruggiero G, Utili R. Streptococcus bovis endocarditis and its association 
with chronic liver disease: an underestimated risk factor. Clin Infect Dis. 
2004;38:1394–400.
 17. Pigrau C, Lorente A, Pahissa A, Martinez-Vazquez JM. Streptococcus 
bovis bacteremia and digestive system neoplasms. Scand J Infect Dis. 
1988;20:459–60.
 18. Bujanda L, Cosme A, Gil I, Arenas-Mirave JI. Malignant colorectal polyps. 
World J Gastroenterol. 2010;16:3103–11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
